Essential criteria for evaluation of pneumococcal conjugate vaccine candidates

被引：16
|
作者：
Paradiso, Peter [1 ]
机构：
[1] Wyeth Pharmaceut, Wyeth Vaccines, Collegeville, PA 19426 USA
来源：
VACCINE | 2009年 / 27卷
关键词：
PCV7; Correlate of immunity; ELISA; ANTIBODY-RESPONSE; CHILDREN; POLYSACCHARIDE; EFFICACY; IMPACT; IMMUNOGENICITY; PNEUMONIA; INFANTS; TRIAL;
D O I：
10.1016/j.vaccine.2009.06.008
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In 2003, the World Health Organization recommended a concentration of enzyme-linked immunosorbent assay (ELISA) immunoglobulin G (IgG) anti-capsular antibody of 0.35 mu g/mL as a reference value that correlates to protection against invasive pneumococcal disease. This threshold can be used to demonstrate immunologic non-inferiority of a new vaccine in comparison trials that use pneumococcal conjugate vaccines (PCVs) as a comparator. An investigational 13-valent PCV (PCV13) compared with seven-valent PCV (PCV7) demonstrated that all of the pneumococcal serotypes contained in PCV13 were immunogenic, with 88-98% of vaccinees achieving antibody concentration >= 035 mu g/mL for serotypes shared with PCV7 and >96% for six additional serotypes. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：C15 / C18
页数：4
相关论文
共 50 条
  • [1] Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants
    Jódar, L
    Butler, J
    Carlone, G
    Dagan, R
    Goldblatt, D
    Käyhty, H
    Klugman, K
    Plikaytis, B
    Siber, G
    Kohberger, R
    Chang, I
    Cherian, T
    [J]. VACCINE, 2003, 21 (23) : 3265 - 3272
  • [2] Conjugate pneumococcal vaccine
    不详
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (01) : 90 - 90
  • [3] Pneumococcal conjugate vaccine
    Ledwith, M
    [J]. CURRENT OPINION IN PEDIATRICS, 2001, 13 (01) : 70 - 74
  • [4] Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
    Hsu, Heather E.
    Shutt, Kathleen A.
    Moore, Matthew R.
    Beall, Bernard W.
    Bennett, Nancy M.
    Craig, Allen S.
    Farley, Monica M.
    Jorgensen, James H.
    Lexau, Catherine A.
    Petit, Susan
    Reingold, Arthur
    Schaffner, William
    Thomas, Ann
    Whitney, Cynthia G.
    Harrison, Lee H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (03): : 244 - 256
  • [5] PNEUMOCOCCAL CONJUGATE VACCINE AND PREVENTION OF PNEUMOCOCCAL INFECTIONS
    Nohynek, H.
    [J]. ACTA PAEDIATRICA, 2011, 100 : 7 - 7
  • [6] Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine
    Yildirim, Inci
    Shea, Kimberly M.
    Pelton, Stephen I.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2015, 29 (04) : 679 - +
  • [7] Into the era of the pneumococcal conjugate vaccine
    Klein, JO
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (17): : S1024 - S1029
  • [8] Pneumococcal conjugate vaccine in children
    Davis, RL
    Fireman, B
    Shinefield, HR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01): : 84 - 85
  • [9] Pneumococcal polysaccharide conjugate vaccine
    不详
    [J]. AUSTRALIAN PRESCRIBER, 2010, 33 (02) : 56 - 57
  • [10] Pneumococcal conjugate vaccine update
    Campos-Outcalt, Doug
    [J]. JOURNAL OF FAMILY PRACTICE, 2019, 68 (10): : 564 - 566
12345